AAAAAA
Results:
1-12
|
Results: 12
Authors:
Garufi, C
Nistico, C
Brienza, S
Vaccaro, A
D'Ottavio, A
Zappala, AR
Aschelter, AM
Terzoli, E
Citation: C. Garufi et al., Single-agent oxaliplatin in pretreated advanced breast cancer patients: A phase II study, ANN ONCOL, 12(2), 2001, pp. 179-182
Authors:
Cosimelli, M
Mancini, R
Tedesco, M
Sperduti, I
Impiombato, FA
Lepiane, P
Graziano, F
Carboni, F
Greco, L
Garufi, C
Coco, C
Morganti, AG
Picciocchi, A
Valentini, V
Citation: M. Cosimelli et al., Preoperative chemoradiation and total mesorectal excision surgery for low T-3 rectal cancer, TUMORI, 87(4), 2001, pp. S31-S33
Authors:
Garufi, C
Brienza, S
Pugliese, P
Aschelter, AM
Bensmaine, MA
Bertheault-Cvitkovic, F
Nistico, C
Giunta, S
Caterino, M
Giannarelli, D
Cosimelli, M
Levi, F
Terzoli, E
Citation: C. Garufi et al., Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancerpatients, ANTI-CANC D, 11(6), 2000, pp. 495-501
Authors:
Garufi, C
Vaglio, S
Brienza, S
Conti, L
D'Attino, RM
Girelli, G
Terzoli, E
Citation: C. Garufi et al., Immunohemolytic anemia following oxaliplatin administration, ANN ONCOL, 11(4), 2000, pp. 497-497
Authors:
Dogliotti, L
Garufi, C
Iacobelli, S
Citation: L. Dogliotti et al., Chronochemotherapy, TUMORI, 86(3), 2000, pp. S32-S36
Authors:
Cure, H
Chevalier, V
Pezet, D
Bousquet, J
Focan, C
Levi, F
Garufi, C
Chipponi, J
Chollet, P
Citation: H. Cure et al., Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer, ANTICANC R, 20(6C), 2000, pp. 4649-4653
Authors:
Nistico, C
Garufi, C
Milella, M
Vaccaro, A
D'Ottavio, AM
Fabi, A
Pace, A
Bove, L
Tropea, F
Marsella, A
Izzo, F
D'Attino, RM
Ferraresi, V
De Marco, S
Terzoli, E
Citation: C. Nistico et al., Weekly schedule of vinorelbine in pretreated breast cancer patients, BREAST CANC, 59(3), 2000, pp. 223-229
Authors:
Nistico, C
Garufi, C
Barni, S
Frontini, L
Galla, DAP
Giannarelli, D
Vaccaro, A
D'Ottavio, AM
Terzoli, E
Citation: C. Nistico et al., Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: A high-activity, dose-dense weekly regimen for advanced breast cancer, ANN ONCOL, 10(8), 1999, pp. 937-942
Authors:
Garufi, C
Dogliotti, L
Terzoli, E
Focan, C
Smaaland, R
Chollet, P
Perpoint, B
Levi, F
Citation: C. Garufi et al., Letter to the Editor, TUMORI, 85(2), 1999, pp. 149-150
Authors:
Pergolizzi, S
Settineri, N
Santacaterina, A
Maisano, R
Frosina, P
Loria, F
Nardella, G
Garufi, C
Sansotta, G
De Renzis, C
Citation: S. Pergolizzi et al., Prognostic factors in ambulatory patients with inoperable locoregionally recurrent rectal canter following curative surgery, ANTICANC R, 19(2B), 1999, pp. 1383-1390
Authors:
Nistico, C
Garufi, C
Milella, M
D'Ottavio, AM
Vaccaro, A
Fabi, A
Terzoli, E
Citation: C. Nistico et al., Weekly epirubicin plus lonidamine in advanced breast carcinoma, BREAST CANC, 56(3), 1999, pp. 233-237
Authors:
Van Cutsem, E
Pozzo, C
Starkhammar, H
Dirix, L
Terzoli, E
Cognetti, E
Humblet, Y
Garufi, C
Filez, L
Gruia, G
Cote, C
Barone, C
Citation: E. Van Cutsem et al., A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer, ANN ONCOL, 9(11), 1998, pp. 1199-1204
Risultati:
1-12
|